These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23735984)

  • 1. Anticoagulation for pediatric mechanical circulatory support.
    Annich G; Adachi I
    Pediatr Crit Care Med; 2013 Jun; 14(5 Suppl 1):S37-42. PubMed ID: 23735984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Side by Side Comparison of Outcomes and Complications With a Simple Versus Intensive Anticoagulation Monitoring Strategy in Pediatric Extracorporeal Life Support Patients.
    Yu JS; Barbaro RP; Granoski DA; Bauman ME; Massicotte MP; Lequier LL; Annich GM; Ryerson LM
    Pediatr Crit Care Med; 2017 Nov; 18(11):1055-1062. PubMed ID: 28922263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of anticoagulation and hemostasis for pediatric extracorporeal membrane oxygenation.
    Saini A; Spinella PC
    Clin Lab Med; 2014 Sep; 34(3):655-73. PubMed ID: 25168949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation management in patients undergoing mechanical circulatory support.
    Görlinger K; Bergmann L; Dirkmann D
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):179-98. PubMed ID: 22910089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin in pediatric patients maintained on extracorporeal life support.
    Nagle EL; Dager WE; Duby JJ; Roberts AJ; Kenny LE; Murthy MS; Pretzlaff RK
    Pediatr Crit Care Med; 2013 May; 14(4):e182-8. PubMed ID: 23648880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.
    Liveris A; Bello RA; Friedmann P; Duffy MA; Manwani D; Killinger JS; Rodriquez D; Weinstein S
    Pediatr Crit Care Med; 2014 Feb; 15(2):e72-9. PubMed ID: 24335992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation Laboratories.
    Winkler AM
    Semin Thromb Hemost; 2017 Apr; 43(3):291-299. PubMed ID: 28166602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation.
    Morrisette MJ; Zomp-Wiebe A; Bidwell KL; Dunn SP; Gelvin MG; Money DT; Palkimas S
    Perfusion; 2020 Jan; 35(1):66-72. PubMed ID: 31213179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation during ECMO in neonatal and paediatric patients.
    Barton R; Ignjatovic V; Monagle P
    Thromb Res; 2019 Jan; 173():172-177. PubMed ID: 29779622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an Anti-Xa-Based Anticoagulation Protocol for Patients with Percutaneous Ventricular Assist Devices.
    Sieg A; Mardis BA; Mardis CR; Huber MR; New JP; Meadows HB; Cook JL; Toole JM; Uber WE
    ASAIO J; 2015; 61(5):502-8. PubMed ID: 26273933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
    Chu DC; Abu-Samra AG; Baird GL; Devers C; Sweeney J; Levy MM; Muratore CS; Ventetuolo CE
    Intensive Care Med; 2015 Feb; 41(2):369-70. PubMed ID: 25465907
    [No Abstract]   [Full Text] [Related]  

  • 16. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist.
    Bein T; Zimmermann M; Philipp A; Ramming M; Sinner B; Schmid C; Müller T; Graf B; Schlitt HJ; Weber-Carstens S
    ASAIO J; 2011; 57(3):164-8. PubMed ID: 21427564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding and Thrombosis With Pediatric Extracorporeal Life Support: A Roadmap for Management, Research, and the Future From the Pediatric Cardiac Intensive Care Society: Part 1.
    Penk JS; Reddy S; Polito A; Cisco MJ; Allan CK; Bembea MM; Giglia TM; Cheng HH; Thiagarajan RR; Dalton HJ
    Pediatr Crit Care Med; 2019 Nov; 20(11):1027-1033. PubMed ID: 31274779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges with Navigating the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation and Transfusion Management.
    Andrews J; Winkler AM
    Transfus Med Rev; 2016 Oct; 30(4):223-9. PubMed ID: 27543261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion From Activated Clotting Time to Anti-Xa Heparin Activity Assay for Heparin Monitoring During Extracorporeal Membrane Oxygenation.
    Figueroa Villalba CA; Brogan TV; McMullan DM; Yalon L; Jordan DI; Chandler WL
    Crit Care Med; 2020 Dec; 48(12):e1179-e1184. PubMed ID: 33009103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions.
    Annich GM; Zaulan O; Neufeld M; Wagner D; Reynolds MM
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):425-439. PubMed ID: 28536932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.